Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q1 2024 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2024-05-15

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value: $126M (100.0% shares, 0.0% debt)

Holdings (20)

EOLS EVOLUS INC 29.7%

Value $37.44M Shares 2,674,356 Est. Cost $8.66 Unrealized +50.1%

ADMA ADMA BIOLOGICS INC 17.9%

Value $22.62M Shares 3,426,882 Est. Cost $2.26 Unrealized +141.4%

— ALIMERA SCIENCES INC 12.5%

Value $15.8M Shares 4,051,072 Est. Cost $3.11 Unrealized —

GLPG GALAPAGOS NV-SPON ADR 10.1%

Value $12.68M Shares 393,634 Est. Cost $36.89 Unrealized —

— REVANCE THERAPEUTICS INC 7.7%

Value $9.724M Shares 1,976,342 Est. Cost $4.92 Unrealized —

XOMA XOMA CORP 4.8%

Value $6.103M Shares 253,770 Est. Cost $19.74 Unrealized +13.5%

TELA TELA BIO INC 3.1%

Value $3.902M Shares 688,200 Est. Cost $8.26 Unrealized -20.2%

— NEKTAR THERAPEUTICS 2.6%

Value $3.251M Shares 3,480,409 Est. Cost $0.93 Unrealized —

MIST MILESTONE PHARMACEUTICALS IN 2.1%

Value $2.618M Shares 1,462,296 Est. Cost $1.62 Unrealized 0.0%

— SCPHARMACEUTICALS INC 1.8%

Value $2.243M Shares 446,776 Est. Cost $5.02 Unrealized —

CALC CALCIMEDICA INC 1.7%

Value $2.174M Shares 522,602 Est. Cost $4.55 Unrealized 0.0%

ANIK ANIKA THERAPEUTICS INC 1.2%

Value $1.548M Shares 60,949 Est. Cost $24.20 Unrealized 0.0%

— RIGEL PHARMACEUTICALS INC 1.2%

Value $1.54M Shares 1,040,241 Est. Cost $1.48 Unrealized —

AYTU AYTU BIOPHARMA INC 1.1%

Value $1.436M Shares 472,469 Est. Cost $1.96 Unrealized +45.7%

XERS XERIS BIOPHARMA HOLDINGS INC 1.0%

Value $1.322M Shares 598,086 Est. Cost $2.16 Unrealized +20.0%

XGN EXAGEN INC 0.5%

Value $612K Shares 384,600 Est. Cost $8.92 Unrealized -78.2%

— ADICET BIO INC 0.3%

Value $333K Shares 141,548 Est. Cost $2.35 Unrealized —

RZLT REZOLUTE INC 0.2%

Value $310K Shares 121,479 Est. Cost $3.88 Unrealized -63.4%

IOBT IO BIOTECH INC 0.2%

Value $270K Shares 156,167 Est. Cost $1.76 Unrealized -1.2%

SCYX SCYNEXIS INC 0.1%

Value $141K Shares 95,637 Est. Cost $2.73 Unrealized -35.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
EOLS	EVOLUS INC	2,674,356	$37.44M	29.7%	$8.66	+50.1%	COM	30052C107
ADMA	ADMA BIOLOGICS INC	3,426,882	$22.62M	17.9%	$2.26	+141.4%	COM	000899104
—	ALIMERA SCIENCES INC	4,051,072	$15.8M	12.5%	$3.11	—	COM NEW	016259202
GLPG	GALAPAGOS NV-SPON ADR	393,634	$12.68M	10.1%	$36.89	—	SPON ADR	36315X101
—	REVANCE THERAPEUTICS INC	1,976,342	$9.724M	7.7%	$4.92	—	COM	761330109
XOMA	XOMA CORP	253,770	$6.103M	4.8%	$19.74	+13.5%	COM NEW	98419J206
TELA	TELA BIO INC	688,200	$3.902M	3.1%	$8.26	-20.2%	COM	872381108
—	NEKTAR THERAPEUTICS	3,480,409	$3.251M	2.6%	$0.93	—	COM	640268108
MIST	MILESTONE PHARMACEUTICALS IN	1,462,296	$2.618M	2.1%	$1.62	0.0%	COM	59935V107
—	SCPHARMACEUTICALS INC	446,776	$2.243M	1.8%	$5.02	—	COM	810648105
CALC	CALCIMEDICA INC	522,602	$2.174M	1.7%	$4.55	0.0%	COM NEW	38942Q202
ANIK	ANIKA THERAPEUTICS INC	60,949	$1.548M	1.2%	$24.20	0.0%	COM	035255108
—	RIGEL PHARMACEUTICALS INC	1,040,241	$1.54M	1.2%	$1.48	—	COM NEW	766559603
AYTU	AYTU BIOPHARMA INC	472,469	$1.436M	1.1%	$1.96	+45.7%	COM	054754858
XERS	XERIS BIOPHARMA HOLDINGS INC	598,086	$1.322M	1.0%	$2.16	+20.0%	COM	98422E103
XGN	EXAGEN INC	384,600	$612K	0.5%	$8.92	-78.2%	COM	30068X103
—	ADICET BIO INC	141,548	$333K	0.3%	$2.35	—	COM	007002108
RZLT	REZOLUTE INC	121,479	$310K	0.2%	$3.88	-63.4%	COM NEW	76200L309
IOBT	IO BIOTECH INC	156,167	$270K	0.2%	$1.76	-1.2%	COM	449778109
SCYX	SCYNEXIS INC	95,637	$141K	0.1%	$2.73	-35.3%	COM NEW	811292200